![]() |
ALT | Altimmune, Inc. |
Pharmaceutical Preparations |
Book value per $ invested | $ 0.36 |
Leverage | 11.34% |
Market Cap | $ 342.3m |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -94.6m |
Margin | -144691.57% |
Altimmune, Inc., a clinical-stage biopharmaceutical company, focuses on the development of intranasal vaccines, immunomodulatory therapies, and treatments for liver disease. The company is headquartered in Gaithersburg, Maryland.